Oxomemazine, Sans Sucre, Édulcorée À L’acésulfame Potassique Unither Pharmaceuticals

Oxomemazine, the active ingredient in Oxomemazine, Sans Sucre, Édulcorée À L’acésulfame Potassique Unither Pharmaceuticals, is a first‑generation antihistamine presented as a tablet for oral use. It is employed to relieve allergic symptoms such as itching, rash, and runny nose in children and adults.

GNH USA supplies Oxomemazine, Sans Sucre, Édulcorée À L’acésulfame Potassique Unither Pharmaceuticals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Oxomemazine is a first‑generation H1‑receptor antagonist that acts on allergic and histamine‑mediated pathways. - Allergic rhinitis: reduces nasal congestion, sneezing and itching. - Acute urticaria: alleviates hives and skin itching. - Pruritus associated with eczema: lessens itch intensity and improves sleep quality.

Adverse reactions to oxomemazine are generally dose‑dependent and may vary with individual sensitivity.

Common Side Effects: - Drowsiness: mild to moderate sedation, especially after the first doses. - Dry mouth: reduced salivary flow causing a sticky sensation. - Dizziness: transient light‑headedness, often resolved with continued use. - Gastrointestinal discomfort: mild nausea or abdominal cramps. - Blurred vision: temporary focusing difficulty.

Serious or Rare Side Effects: - Cardiac arrhythmias: irregular heart rhythm requiring medical evaluation. - Severe allergic reaction: rash, swelling, or airway compromise. - Extrapyramidal symptoms: involuntary muscle movements or tremor. - Hepatotoxicity: abnormal liver enzymes indicating liver stress. - Hematologic abnormalities: low white blood cell or platelet counts.

When prescribing oxomemazine, clinicians should consider several safety aspects. - Pregnancy: avoid use unless the benefit outweighs potential risk to the fetus. - Breastfeeding: contraindicated as the drug passes into milk and may cause sedation in the infant. - Elderly patients: start with the lowest effective dose and monitor for excessive sedation. - Concomitant CNS depressants: may enhance drowsiness and impair coordination. - Driving or operating machinery: advise patients to refrain until they know how the drug affects them. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Oxomemazine may interact with other medicines that influence the central nervous system or cardiac conduction.

Major Interactions (Avoid): - Other antihistamines: additive sedation and anticholinergic load. - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - QT‑prolonging agents: increased potential for arrhythmias.

Moderate Interactions (Monitor Closely): - Alcohol: enhances drowsiness and psychomotor impairment. - Opioid analgesics: may potentiate respiratory depression. - Sedative‑hypnotics: increased risk of profound sedation. - Anticholinergic drugs: heightened dry‑mouth and constipation effects.